Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 3/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | RHOA | P61586 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22323630 | 0.82 | GSR (0.43) | CYP3A4CYP2C19ALDH1A1GSRMEN1 | |
| SCHEMBL27329088 | 0.79 | GSR (0.39) | CYP3A4CYP2C19ALDH1A1SMN1; SMN2GSR | |
| SCHEMBL7594456 | 0.78 | GSR (0.38) | CYP2C19SMN1; SMN2GSRMEN1MAPT | |
| SCHEMBL27847496 | 0.77 | KMT2A (0.46) | CYP3A4ALDH1A1TSHRHSD17B10SMN1; SMN2 | |
| SCHEMBL4441195 | 0.76 | GSR (0.39) | CYP3A4ALDH1A1GSRMEN1MAPT | |
| Acrylic Acid SCHEMBL10943129 | 0.75 | HCAR2 (0.39) | CYP2C19ALDH1A1SMN1; SMN2GSRMEN1 | |
| SCHEMBL286963 | 0.75 | GSR (0.43) | CYP3A4ALDH1A1GSRMAPTKMT2A | |
| SCHEMBL3122035 | 0.75 | ALOX5 (0.42) | ALDH1A1HSD17B10SMN1; SMN2GSRMEN1 | |
| SCHEMBL16776781 | 0.74 | CYP3A4 (0.45) | CYP3A4CYP2C19ALDH1A1TSHRHSD17B10 | |
| SCHEMBL5932816 | 0.74 | GSR (0.42) | CYP3A4ALDH1A1GSRMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220133905-A1 | METHODS FOR ASSEMBLING SCAVENGING PARTICLES | NANOTICS, LLC | 2022-05-05 | — | — | US | disclosed |
| US-11065345-B2 | Methods for assembling scavenging particles | NANOTICS, LLC (US) | 2021-07-20 | — | — | US | disclosed |
| CN-212451364-U | Flow cell and sequencing kit | 伊鲁米那股份有限公司 | 2021-02-02 | — | — | CN | disclosed |
| CN-111321054-A | Flow cell and sequencing kit | 伊鲁米那股份有限公司 | 2020-06-23 | — | — | CN | disclosed |
| US-20200179531-A1 | METHODS FOR ASSEMBLING SCAVENGING PARTICLES | NANOTICS, LLC | 2020-06-11 | — | — | US | disclosed |
| US-10653790-B2 | Compositions and methods related to scavenger particles | NANOTICS, LLC (US) | 2020-05-19 | — | — | US | disclosed |
| EP-3565604-A1 | METHODS FOR ASSEMBLING SCAVENGING PARTICLES | Nanotics, LLC (US) | 2019-11-13 | — | — | EP | disclosed |
| WO-2018213365-A1 | COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-11-22 | — | — | WO | disclosed |
| EP-3383852-A2 | COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | Children's Medical Center Corporation (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20180214566-A1 | COMPOSITIONS AND METHODS RELATED TO SCAVENGER PARTICLES | NANOTICS, LLC | 2018-08-02 | — | — | US | disclosed |
| EP-2609135-A2 | POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF | Massachusetts Institute Of Technology (US) | 2013-07-03 | — | — | EP | disclosed |
| US-20130079376-A1 | PYRIDYL-2-METHYLAMINO COMPOUNDS, COMPOSITIONS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-03-28 | — | — | US | disclosed |
| WO-2012135615-A2 | ENOPEPTINS, USES THEREOF, AND METHODS OF SYNTHESIS THERETO | BROWN UNIVERSITY (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012047907-A9 | SYNTHESIS OF C5-SUBSTITUTED TETRACYCLINES, USES THEREOF, AND INTERMEDIATES THERETO | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012047907-A1 | SYNTHESIS OF C5-SUBSTITUTED TETRACYCLINES, USES THEREOF, AND INTERMEDIATES THERETO | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012027675-A2 | POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-03-01 | — | — | WO | disclosed |
| EP-2389357-A1 | ANTI-INFLAMMATORY COMPLEXES | Signum Biosciences, Inc. (US) | 2011-11-30 | — | — | EP | disclosed |
| US-8038936-B2 | Cooking device with deodorization | LG ELECTRONICS INC. (KR) | 2011-10-18 | — | — | US | disclosed |
| WO-2010090845-A1 | ANTI-INFLAMMATORY COMPLEXES | SIGNUM BIOSCIENCES, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
| CN-101360513-A | Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof | KOREA INST SCI & TECH (KR) | 2009-02-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079376-A1 | PYRIDYL-2-METHYLAMINO COMPOUNDS, COMPOSITIONS AND USES THEREOF | PARK7, PSEN2, PRNP | CYP3A4 1848/4885CYP2C19 792/4885ALDH1A1 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.